YIKES! 220 Pounds of Graphite in Each EV Battery?

Most don't know that today's EV batteries contain more graphite than any other essential ingredient... more than lithium, copper or aluminum! The megatrend of electrifying vehicles only adds to graphite demand, expected to skyrocket 1,050% by 2030. Investors have been frustrated in their search for a Made In America solution – until now.

AVIR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.80%

Insider Buying (Last 12 Months): $102,840.00

Insider Selling (Last 12 Months): $214,741.56

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

^$4.60

▼ -0.06 (-1.29%)

As of 12/7/2022 04:20 PM ET

Days: 30 | 90 | 365

Want To Catch The Next Hot Investing Trend (Look Inside?)

From Investing Trends | Ad

While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...

And It Could Spark An Economic Boom For Investors

Atea Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2022	Franklin M Berger	Director	Sell	16,166	$5.16	$83,416.56	778,353
11/11/2022	Franklin M Berger	Director	Sell	25,500	$5.15	$131,325.00	794,519
12/20/2021	Polly A. Murphy	Director	Buy	12,000	$8.57	$102,840.00

Want To Catch The Next Hot Investing Trend (Look Inside?)

From Investing Trends | Ad

While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55...

And It Could Spark An Economic Boom For Investors

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

69.27% of Atea Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/21/2022	California State Teachers Retirement System	94,592	$0.54M	0.0%	-3.0%	0.114%
11/16/2022	Balyasny Asset Management LLC	751,073	$4.27M	0.0%	-58.3%	0.902%
11/15/2022	State Street Corp	1,894,736	$10.78M	0.0%	+5.1%	2.275%
11/15/2022	Jacobs Levy Equity Management Inc.	380,517	$2.17M	0.0%	-12.0%	0.457%
11/15/2022	Algert Global LLC	21,624	$0.12M	0.0%	-15.1%	0.026%
11/15/2022	Two Sigma Investments LP	98,482	$0.56M	0.0%	-10.9%	0.118%
11/15/2022	UBS Asset Management Americas Inc.	87,448	$0.50M	0.0%	-13.9%	0.105%
11/15/2022	Vanguard Group Inc.	7,584,256	$43.16M	0.0%	+5.6%	9.106%
11/15/2022	Price T Rowe Associates Inc. MD	27,621	$0.16M	0.0%	+19.7%	0.033%
11/15/2022	Martingale Asset Management L P	230,364	$1.31M	0.0%	+57.5%	0.277%
11/15/2022	EcoR1 Capital LLC	6,184,861	$35.19M	1.0%	-2.5%	7.426%
11/15/2022	Federated Hermes Inc.	3,626,818	$20.64M	0.1%	+1.1%	4.354%
11/15/2022	First Trust Advisors LP	199,279	$1.13M	0.0%	N/A	0.239%
11/15/2022	Bank of New York Mellon Corp	306,856	$1.75M	0.0%	+13.6%	0.368%
11/15/2022	BlackRock Inc.	7,871,121	$44.79M	0.0%	+6.3%	9.450%
11/14/2022	Royal Bank of Canada	4,536	$26K	0.0%	+123.6%	0.005%
11/14/2022	LMR Partners LLP	33,552	$0.19M	0.0%	-51.2%	0.040%
11/14/2022	PDT Partners LLC	68,754	$0.39M	0.1%	N/A	0.083%
11/14/2022	Renaissance Technologies LLC	597,400	$3.40M	0.0%	-9.9%	0.717%
11/14/2022	Lazard Asset Management LLC	10,109	$57K	0.0%	-32.4%	0.012%
11/14/2022	Nuveen Asset Management LLC	347,923	$1.98M	0.0%	+28.8%	0.418%
11/14/2022	MetLife Investment Management LLC	47,234	$0.27M	0.0%	+20.9%	0.057%
11/10/2022	Tower Research Capital LLC TRC	17,805	$0.10M	0.0%	-24.2%	0.021%
11/10/2022	UBS Group AG	15,417	$88K	0.0%	+37.0%	0.019%
11/7/2022	Virtu Financial LLC	30,693	$0.18M	0.0%	N/A	0.037%
11/4/2022	CM Management LLC	250,000	$1.42M	1.6%	+25.0%	0.300%
11/4/2022	Prudential Financial Inc.	294,635	$1.68M	0.0%	-22.3%	0.354%
11/3/2022	Barclays PLC	37,023	$0.21M	0.0%	-21.1%	0.044%
11/2/2022	Los Angeles Capital Management LLC	177,148	$1.01M	0.0%	-12.1%	0.213%
10/31/2022	SG Americas Securities LLC	78,839	$0.45M	0.0%	+20.7%	0.095%
10/27/2022	Strs Ohio	91,100	$0.52M	0.0%	-4.1%	0.109%
10/26/2022	Allspring Global Investments Holdings LLC	11,267	$64K	0.0%	+468.8%	0.014%
10/25/2022	Denali Advisors LLC	4,400	$25K	0.0%	N/A	0.005%
9/16/2022	Federated Hermes Inc.	3,588,131	$25.48M	0.1%	+74.9%	4.310%
8/22/2022	Legal & General Group Plc	28,507	$0.20M	0.0%	+130.0%	0.034%
8/22/2022	ExodusPoint Capital Management LP	11,727	$83K	0.0%	N/A	0.014%
8/18/2022	Goldman Sachs Group Inc.	227,220	$1.61M	0.0%	+12.7%	0.273%
8/16/2022	Price T Rowe Associates Inc. MD	23,081	$0.16M	0.0%	-94.8%	0.028%
8/16/2022	Prudential Financial Inc.	379,335	$2.69M	0.0%	-15.2%	0.456%
8/15/2022	AQR Capital Management LLC	108,297	$0.77M	0.0%	-61.5%	0.130%
8/15/2022	State Street Corp	1,803,368	$12.80M	0.0%	-3.7%	2.166%
8/15/2022	Wexford Capital LP	25,000	$0.18M	0.0%	N/A	0.030%
8/15/2022	Cubist Systematic Strategies LLC	26,656	$0.19M	0.0%	-78.6%	0.032%
8/15/2022	UBS Asset Management Americas Inc.	101,586	$0.72M	0.0%	+529.1%	0.122%
8/13/2022	Ronald Blue Trust Inc.	8,700	$63K	0.0%	N/A	0.010%
8/13/2022	Teacher Retirement System of Texas	14,088	$100K	0.0%	N/A	0.017%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	10,090	$72K	0.0%	+190.9%	0.012%
8/13/2022	Renaissance Technologies LLC	663,000	$4.71M	0.0%	-43.1%	0.796%
8/13/2022	American International Group Inc.	35,712	$0.25M	0.0%	+11.4%	0.043%
8/12/2022	Northern Trust Corp	693,126	$4.92M	0.0%	+23.8%	0.832%
8/12/2022	Virtus ETF Advisers LLC	15,548	$0.11M	0.0%	-19.6%	0.019%
8/12/2022	Credit Suisse AG	54,042	$0.38M	0.0%	+232.2%	0.065%
8/12/2022	FMR LLC	12,539,475	$89.03M	0.0%	-0.3%	15.061%
8/12/2022	Rhumbline Advisers	109,712	$0.78M	0.0%	+33.4%	0.132%
8/11/2022	Deutsche Bank AG	266,578	$1.89M	0.0%	+8.0%	0.320%
8/11/2022	UBS Group AG	11,251	$80K	0.0%	-61.2%	0.014%
8/11/2022	JPMorgan Chase & Co.	44,605	$0.32M	0.0%	-79.7%	0.054%
8/10/2022	Principal Financial Group Inc.	13,326	$94K	0.0%	N/A	0.016%
8/9/2022	Swiss National Bank	176,200	$1.25M	0.0%	+382.7%	0.212%
8/9/2022	Lazard Asset Management LLC	14,960	$0.11M	0.0%	+37.1%	0.018%
8/5/2022	Los Angeles Capital Management LLC	201,474	$1.43M	0.0%	-13.1%	0.242%
8/3/2022	Envestnet Asset Management Inc.	17,107	$0.12M	0.0%	+16.4%	0.021%
8/2/2022	Congress Asset Management Co. MA	174,043	$1.24M	0.0%	-3.9%	0.209%
8/1/2022	Victory Capital Management Inc.	41,967	$0.30M	0.0%	-4.4%	0.050%
8/1/2022	ProShare Advisors LLC	15,055	$0.11M	0.0%	-27.3%	0.018%
7/29/2022	SG Americas Securities LLC	65,320	$0.46M	0.0%	N/A	0.078%
7/29/2022	Russell Investments Group Ltd.	3,603	$26K	0.0%	-62.2%	0.004%
7/28/2022	Arizona State Retirement System	20,269	$0.14M	0.0%	N/A	0.024%
7/28/2022	Privium Fund Management UK Ltd	61,284	$0.44M	0.5%	N/A	0.074%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	20,401	$0.15M	0.0%	N/A	0.025%
7/25/2022	Strs Ohio	95,000	$0.67M	0.0%	-23.2%	0.114%
6/30/2022	Amalgamated Bank	8,080	$58K	0.0%	N/A	0.010%
6/7/2022	Bank of America Corp DE	37,513	$0.27M	0.0%	-69.8%	0.045%
5/20/2022	The Manufacturers Life Insurance Company	258,655	$1.86M	0.0%	+15.6%	0.311%
5/17/2022	Royal Bank of Canada	5,568	$41K	0.0%	-50.5%	0.007%
5/16/2022	California State Teachers Retirement System	41,985	$0.30M	0.0%	-14.5%	0.050%
5/16/2022	Goldman Sachs Group Inc.	201,693	$1.46M	0.0%	-27.9%	0.242%
5/16/2022	PDT Partners LLC	224,660	$1.62M	0.1%	-19.3%	0.270%
5/16/2022	Wellington Management Group LLP	88,341	$0.64M	0.0%	+24.2%	0.106%
5/16/2022	State Street Corp	1,872,074	$13.52M	0.0%	-19.5%	2.249%
5/16/2022	Prelude Capital Management LLC	10,200	$74K	0.0%	N/A	0.012%
5/16/2022	Graham Capital Management L.P.	75,817	$0.55M	0.0%	+126.9%	0.091%
5/16/2022	Invesco Ltd.	105,018	$0.76M	0.0%	+215.4%	0.126%
5/16/2022	UBS Group AG	29,005	$0.21M	0.0%	-72.3%	0.035%
5/13/2022	Renaissance Technologies LLC	1,165,000	$8.41M	0.0%	+87.7%	1.399%
5/13/2022	Northern Trust Corp	560,020	$4.04M	0.0%	-2.7%	0.673%
5/13/2022	Charles Schwab Investment Management Inc.	414,597	$2.99M	0.0%	+4.9%	0.498%
5/13/2022	Lazard Asset Management LLC	10,908	$78K	0.0%	+26.7%	0.013%
5/13/2022	Prudential Financial Inc.	447,115	$3.23M	0.0%	+16.9%	0.537%
5/13/2022	Federated Hermes Inc.	2,051,332	$14.81M	0.0%	N/A	2.464%
5/13/2022	American International Group Inc.	32,065	$0.23M	0.0%	-6.6%	0.039%
5/13/2022	Vanguard Group Inc.	6,729,203	$48.58M	0.0%	+16.4%	8.082%
5/12/2022	BlackRock Inc.	6,624,693	$47.83M	0.0%	+14.6%	7.957%
5/12/2022	Rhumbline Advisers	82,237	$0.59M	0.0%	-4.6%	0.099%
5/12/2022	Metropolitan Life Insurance Co NY	4,928	$36K	0.0%	-73.9%	0.006%
5/12/2022	MetLife Investment Management LLC	39,066	$0.28M	0.0%	+58.5%	0.047%
5/12/2022	Martingale Asset Management L P	146,128	$1.06M	0.0%	+50.5%	0.176%
5/12/2022	Acadian Asset Management LLC	852,576	$6.15M	0.0%	+213.1%	1.024%
5/12/2022	Capital Fund Management S.A.	35,565	$0.26M	0.0%	N/A	0.043%
5/12/2022	PNC Financial Services Group Inc.	5,000	$36K	0.0%	-96.4%	0.006%

Data available starting January 2016

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $4.60

$4.57

$4.67

50 Day Range

MA: $5.29

$4.52

$6.06

52 Week Range

Now: $4.60

$4.45

$9.79

Volume

8,233 shs

Average Volume

468,418 shs

Market Capitalization

$383.13 million

P/E Ratio

13.14

Dividend Yield

N/A

Beta

0.24

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?: Atea Pharmaceuticals' top insider investors include:
Franklin M Berger (Director)
Polly A Murphy (Director)
Learn More about top insider investors at Atea Pharmaceuticals.
Who are the major institutional investors of Atea Pharmaceuticals?: Atea Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 9.45%
Vanguard Group Inc. — 9.11%
EcoR1 Capital LLC — 7.43%
Federated Hermes Inc. — 4.35%
State Street Corp — 2.27%
Balyasny Asset Management LLC — 0.90%
Learn More about top institutional investors of Atea Pharmaceuticals stock.
Which institutional investors are selling Atea Pharmaceuticals stock?: In the last quarter, AVIR stock was sold by these institutional investors:
Balyasny Asset Management LLC
EcoR1 Capital LLC
Prudential Financial Inc.
Renaissance Technologies LLC
Jacobs Levy Equity Management Inc.
LMR Partners LLP
Los Angeles Capital Management LLC
UBS Asset Management Americas Inc.
Which institutional investors are buying Atea Pharmaceuticals stock?: Within the previous quarter, AVIR stock was bought by institutional investors including:
BlackRock Inc.
Vanguard Group Inc.
First Trust Advisors LP
State Street Corp
Martingale Asset Management L P
Nuveen Asset Management LLC
PDT Partners LLC
CM Management LLC

YIKES! 220 Pounds of Graphite in Each EV Battery?

From Investing Trends | Ad

See Why Savvy Investors Could Benefit

AVIR Insider Trading

Atea Pharmaceuticals Insider Trading History Chart

Atea Pharmaceuticals Share Price & Price History

Atea Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Atea Pharmaceuticals (NASDAQ:AVIR)

Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Atea Pharmaceuticals?

Who are the major institutional investors of Atea Pharmaceuticals?

Which institutional investors are selling Atea Pharmaceuticals stock?

Which institutional investors are buying Atea Pharmaceuticals stock?